Product References — Antibodies
Discover the Innovative Research Product Catalog: Watch Now to Explore Our Offerings
Posted by Adam Awdish on
Looking to optimize your research tools and set your lab up for success? Our recent YouTube video, hosted by Maria Granger, VP of Sales for the Midwest region, is your gateway to understanding the depth of Innovative Research’s catalog. With over 25 years of expertise, we’re committed to providing reliable in vitro research biologicals to drive scientific progress. From human and animal blood products to specialized cell culture tools and ELISA kits, this video showcases everything you need to advance your experiments. Maria also shares insights into our standout customer service and why researchers worldwide trust Innovative Research. Why watch...
- Tags: academic research, Animal Blood Cells, Animal Plasma, Animal Serum, Animal Tissues Organs, Animal Whole Blood, Antibodies, Bio Fluids, company news, ELISA Kit, ELISA Kits, Human Biological Fluids, Human Blood Cells, Human Cancer-State, Human Deficient Plasma, Human Plasma, Human Serum, molecular innovations, Monoclonal Antibodies
Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
Posted by Adam Awdish on
In the ever-evolving landscape of molecular biology, precision tools are essential for elucidating complex biological processes. Specifically, when looking at scientific advancement in the field of diagnostic development, the role of specific monoclonal antibodies in understanding and manipulating biological processes cannot be overstated. Innovative Research offers a suite of monoclonal antibodies, including an array of PAI-1 monoclonals, designed to empower researchers in their quest for scientific discovery. What is PAI-1? Plasminogen Activator Inhibitor-1 (PAI-1) is a protein that functions as the principal inhibitor of tissue plasminogen activator and urokinase plasminogen activator, two enzymes responsible for the conversion of plasminogen...
- Tags: academic research, Antibodies, Bio Fluids, Human Biological Fluids, Monoclonal Antibodies, PAI-1
Pioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
Posted by Adam Awdish on
In the dynamic landscape of medical research, SAR443809 emerges as a promising candidate for the treatment of complement-mediated disorders. Complement-mediated disorders pose a significant challenge in healthcare, marked by the immune system erroneously targeting healthy cells. Central to these disorders is the complement alternative pathway, an integral part of our immune response. When dysregulated, it can precipitate severe and potentially fatal conditions. This groundbreaking study unveils the potential of a humanized IgG4 monoclonal antibody, specifically designed to selectively inhibit the complement alternative pathway, thereby opening new therapeutic avenues for patients globally. Key Insights from Recent Research SAR443809 distinguishes itself with...
Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity
Posted by Adam Awdish on
Human Factor II (Prothrombin) Purified, Human Fibrinogen Purified, and Rabbit Anti Mouse/Rat Fibrinogen Polyclonal Affinity Purified from Innovative Research were used in the following study: Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity Alice G. Cheng, Molly McAdow, Hwan K. Kim, Taeok Bae, Dominique M. Missiakas, Olaf Schneewind PLOS Pathogens August 5, 2010 Staphylococcus aureus is a bacterium responsible for many common infections, including bacteremia, pneumonia, soft tissue infections, and septic arthritis among others. There remains no known way to gain protective immunity against S. aureus diseases, and researchers continue to investigate options for an effective vaccine....
- Tags: Antibodies, Bio Fluids, Human Biological Fluids, human factor ii (prothrombin) purified, human fibrinogen purified, rabbit anti mouse/rat fibrinogen polyclonal affinity purified
Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib
Posted by Adam Awdish on
Rabbit Anti Mouse Antiplasmin Polyclonal Fractionated HRP Labeled from Innovative Research was used in the following study: Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib Yusuke Yamashita, Shuhei Morita, Hiroki Hosoi, Hiroshi Kobata, Shohei Kishimoto, Tatsuya Ishibashi, Hiroyuki Mishima, Akira Kinoshita, Bradley J. Backes, Koh-Ichiro Yoshiura, Feroz R. Papa, Takashi Sonoki, and Shinobu Tamura International Journal of Molecular Sciences August 31, 2020 Inositol-requiring enzyme 1α (IRE1α) and protein kinase R-like endoplasmic reticulum kinase (PERK) are key regulators of the unfolded protein response (UPR). The UPR is a cellular mechanism that helps...
- Tags: Antibodies